Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones

Gut

Volumn 38, Issue 5, 1996, Pages 775-783

  Hussaini, S H ^a   Pereira, S P ^a   Veysey, M J ^a   Kennedy, C ^b   Jenkins, P ^c   Murphy, G M ^a   Wass, J A H ^c   Dowling, R H ^a,b  

^a G   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

deoxycholic acid; gall bladder emptying; gall bladder stones; large bowel transit time; mouth to caecum transit time; octreotide

Indexed keywords

GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADULT; ARTICLE; CHOLELITHIASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; FEMALE; GALLBLADDER EMPTYING; GALLSTONE FORMATION; HUMAN; INTESTINE TRANSIT TIME; MALE; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030000036     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.5.775     Document Type: Article

References (56)

1. Ho KY, Weissberger AJ, Marbach P, Lazarus L. Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Ann Intern Med 1990; 112: 173-81.
2. Dowling RH, Hussaini SH, Murphy GM, Besser GM, Wass JAH. Gallstones during octreotide therapy. Metabolism 1992; 41 (S2): 22-33.
3. Dowling RH, Gleeson D, Ruppin DC, Murphy GM. Gallstone recurrence and post-dissolution management. In: Paumgartner G, Stiehl A, Gerok W, eds. Enterohepatic circulation of bile acids and sterol metabolism. Lancaster, England: MTP Press, 1984: 361-70.
4. van Liessum PA, Hopman WP, Pieters GF, Jansen JB, Smals AG, Rosenbusch G, et al. Post prandial gallbladder motility during long term treatment with the long-acting somatostatin analogue SMS 201-955 in acromegaly. J Clin Endocrinol Metab 1989; 69: 557-62.
5. Catnach SM, Anderson JV, Fairclough PD, Trembath RC, Wilson PAJ, Parker E, et al. The effect of octreotide on gallstone prevalence and gallbladder motility in acromegaly. Gut 1993; 34: 270-3.
6. Stolk MFJ, van Erpecum KJ, Koppeschaar HPF, de Bruin WI, Jansen JBM, Lamers CBWH, et al. Postprandial gallbladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly. Gut 1993; 34: 808-13.
7. Lembcke B, Creutzfeldt S, Schlesser R, Ebert R, Shaw C, Koop I. Effect of somatostatin analogue (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal man. Digestion 1987; 36: 108-24.
8. Creutzfeldt W, Lembcke B, Follsh UR, Schleser S, Koop I. The effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretions in humans. Am J Med 1987; 82: 49-54.
9. Hussaini SH, Murphy GM, Kennedy C, Besser GM, Wass JAH, Dowling RH. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. Gastroenterology 1994; 107: 1503-13.
10. Thornton JR, Heaton KW. Do colonic bacteria contribute to cholesterol gall stone formation? Effects of lactulose on bile. BMJ 1981; 282: 1018-20.
11. Thornton JR, Emmett PM, Heaton KW. Diet and gallstones: effects of refined and unrefined carbohydrate diets on bile cholesterol saturation and bile acid metabolism. Gut 1983; 25: 269-74.
12. Marcus SN, Heaton KW. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile: three interrelated factors. Gut 1986; 27: 550-8.
13. Carey MC, Cahalane MJ. Whither biliary sludge. Gastroenterology 1988; 95: 508-23.
14. Roda E, Aldini R, Mazella G, Roda A, Sama C, Festi D, et al. Enterohepatic circulation of bile acids after cholecystectomy. Gut 1978; 19: 640-9.
15. Kullak-Ublick GA, Paumgartner G, Berr F. Long-term effects of cholecystectomy on bile acid metabolism. Hepatology 1995; 21: 41-5.
16. Fuessl HS, Carolan G, Williams G, Bloom SR. Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man. Digestion 1987; 36: 101-7.
17. Hopman WP, van Liessum PA, Pieters GF, Jansen JB, Lamers CB, Smals AG, et al. Postprandial gallbladder motility and plasma cholecystokinin at regular time intervals after injection of octreotide in acromegalics on long-term treatment. Dig Dis Sci 1992; 37: 1685-90.
18. von der Ohe MR, Camilleri M, Thomforde GM, Klee GG. Differential regional effects of octreotide on human gastrointestinal motor function. Gut 1995; 36: 743-8.
19. Dodds WJ, Groh WJ, Darweesh RMA, Lawson TL, Kishk SMA, Kern MK. Sonographic measurement of gallbladder volume. Am J Roentgenol 1985; 145: 1009-11.
20. Bond JH, Levitt MD. Investigation of small bowel transit time in man utilizing pulmonary hydrogen measurements. J Lab Clin Med 1974; 85: 546-56.
21. Howard PJ, Lazarus C, Maisey MN, Dowling RH. Interpretation of postprandial breath hydrogen excretion in relation to small bowel transit and ileocecal flow patterns of a radiolabeled solid meal in man. J Gastrointest Motil 1990; 2: 194-201.
22. Metcalf AM, Phillips SF, Zinsmeister AR, MacCarty RL, Bean RW, Wolff BG. Simplified assessment of segmental colonic transit. Gastroenterology 1987; 92: 40-7.
23. Deuno MI, Bai JC, Sanangelo WC, Krejs GJ. The effect of somatostatin analogue on water and electrolyte transport and transit time in human small bowel. Dig Dis Sci 1987; 32: 1092-6.
24. Møller N, Petrany G, Cassidy D, Sheldon WJ, Johnston DG, Laker MF. Effects of somatostatin analogue SMS 201-995 (sandostatin) on mouth-to-caecum transit time and absorption of fat and carbohydrates in normal man. Clin Sci 1988; 750: 345-50.
25. O'Donnell LJD, Watson AJM, Cameron D, Farthing MJG. Effect of octreotide on mouth-to-caecum transit time in healthy subjects and in the irritable bowel syndrome. Aliment Phamacol Therap 1990; 4: 177-82.
26. Nicholl CG, Polak JM, Bloom SR. The hormonal regulation of food intake, digestion, and absorption. Nutrition 1985; 5: 213-39.
27. Torsoli A, Severi C. The neuroendocrine control of gastrointestinal motor activity. J Physiol 1993; 87: 367-74.
28. Wald A, van Thiel DH, Hoechstetter L, Gavaler JS, Egler KM, Verm R, et al. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981; 80: 1497-500.
29. Fich A, Camilleri M, Phillips SF. Effect of age on human gastric and small bowel motility. J Clin Gastroenterol 1989; 11: 416-20.
30. Kupfer RM, Heppell M, Haggith JW, Bateman DN. Gastric emptying and small bowel transit in the elderly. J Am Geriatr Soc 1985; 33: 340-3.
31. Wegener MG, Scharffstein J, Lüth J, Rickels R, Ricken D. The effect of ageing on the gastrointestinal transit of a lactulose supplemental solid-liquid meal in humans. Digestion 1988; 39: 40-6.
32. Piccione PR, Holt PR, Culpepper-Morgan JA, Paris P, O'Bryan L, Ferdinands L. Intestinal dysmotility syndromes in the elderly: measurements of oro-cecal transit time. Am J Gastroenterol 1990; 82: 161-4.
33. Mitsukawa T, Takemura J, Nishizono F, Nakatsuru K, Ohgo S, Matsukura S. Effects of atropine, proglumide, and somatostatin analogue (SMS 201-995) on bombesin-induced gallbladder contraction and CCK secretion in humans. Am J Gastroenterol 1989; 84: 1371-4.
34. Zhu XF, Shi YF, Qin-Dai, Zhang JX, Harns AG. Effect of small doses of somatostatin analog, octreotide, on gallbladder contractility in normal Chinese adults. Dig Dis Sci 1992; 37: 105-8.
35. Bigg-Wither GW, Ho KYY, Grunstein RR, Sullivan CE, Doust BD. Effect of long term octreotide on gall stone formation and gallbladder function. BMJ 1992; 304: 1611-2.
36. Ewins DL, Javaid A, Coskeran PB, Shah S, Butler J, Deprez PH, et al. Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly. Q J Med 1992; 83: 295-306.
37. Rhodes M, James RA, Bird M, Clayton B, Kendall-Taylor P, Lennard TW. Gallbladder function in acromegalic patients taking long-term octreotide: evidence of rebound hypermotility on cessation of treatment. Scand J Gastroenterol 1992; 27: 115-8.
38. Binmoeller KF, Dumas R, Harris AG, Delmont JP. Effect of somatostatin analogue octreotide on human sphincter of oddi. Dig Dis Sci 1992; 37: 773-7.
39. Takahashi I, Suzuki T, Aizawa I, Itoh Z. Comparison of gallbladder contractions induced by motilin and cholecystokinin in dogs. Gastroenterology 1982; 82: 419-24.
40. Guilliemin R. Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus. Endocrinology 1976; 99: 1653-4.
41. Cullen JJ, Eagon JC, Dozois EJ, Kelly KA. Treatment of acute postoperative ileus with octreotide. Am J Surg 1993; 165: 113-9.
42. Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991; 325: 1461-7.
43. Richards WO, Geer R, O'Dorisio TM, Robarts T, Parish KL, Rice D, et al. Octreotide acetate induces fasting small bowel motility in patients with the dumping syndrome. J Surg Res 1990; 49: 483-7.
44. Hostein J, Janssens J, Vantrappen G, Peeters TL, Vandeweerd M, Leman G. Somatostatin induces ectopic activity fronts of the migrating motor complex via a local intestinal mechanism. Gastroenterology 1984; 87: 1004-8.
45. Pomare EW, Heaton KW. The effect of cholecystectomy on bile acid metabolism. Gut 1973; 14: 753-62.
46. Shaffer E, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest 1977; 59: 828-40.
47. Hepner GW, Hofmann AF, Malagelada JR, Szezepanik PA, Klien PD. Increased bacterial degradation of bile acids in cholecystectomized patients. Gastroenterology 1974; 66: 556-64.
48. van der Linden W, Katzenstein B, Nakayama F. The possible carcinonogenic effect of cholecystectomy: no post-operative increase in the proportion of secondary bile acids. Cancer 1983; 52: 1265-8.
49. Berr F, Stellaard F, Pratschke E, Paumgartner G. Effects of cholecystectomy on the kinetics of primary and secondary bile acids. J Clin Invest 1989; 83: 1541-50.
50. Efendic S, Mattsson O. Effect of somatostatin on intestinal motility. Acta Radiol 1978; 19: 348-52.
51. Johansson C, Efendic S, Wisen O, Uvnas-Wallensten K, Luft R. Effects of short time somatostatin infusion on gastric and intestinal propulsion in humans. Scand J Gastroenterol 1978; 13: 481-3.
52. Konturek SJ. Somatostatin and gastrointestinal secretion and motility. Adv Exp Med Biol 1978; 106: 227-34.
53. Johansson C, Efendic S, Wisen O, Uvnas-Wallensten K. Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. Digestion 1981; 22: 126-37.
54. MacDonald IA, Bokkenheuser VD, Winter J, McLernon AM, Mosbach EH. Degradation of steroids in the human gut. J Lipid Res 1983; 24: 675-700.
55. Morris JS, Low-Beer TS, Heaton KW. Bile salt metabolism in the colon. Scand J Gastroenterol 1973; 8: 425-31.
56. Yahiro K, Setoguchi T, Katsuki T. Effect of cecum and appendix on 7 alpha-dehydroxylation and 7 beta-epimerization of chenodeoxycholic acid in the rabbit. J Lipid Res 1980; 21: 215-22.